Detalhe da pesquisa
1.
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.
Clin Infect Dis
; 78(6): 1617-1628, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180851